Showing results (21-30 of 115) with videos related to
Sort By:
Pageof 12
Proceedings of the National Academy of Sciences of the United States of America|March 3, 2009
Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measuresLi Li, Persis Wadia, Rong Chen, et al.Blood|August 31, 2012
Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemiaCharles Gawad, Francois Pepin, Victoria E H Carlton, et al.Haematologica|August 8, 2015
Risks and benefits of sex-mismatched hematopoietic cell transplantation differ according to conditioning strategyHideki Nakasone, Mats Remberger, Lu Tian, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2023
Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment ResistanceSheren Younes, Shuchun Zhao, Sushma Bharadwaj, et al.British Journal of Haematology|April 21, 2015
Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell diseaseRobert S Nickel, Jeanne E Hendrickson, Marianne M Yee, et al.Transplantation|June 29, 2011
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantationFabrice Porcheray, David B Miklos, Blair H Floyd, et al.Transplantation and Cellular Therapy|October 25, 2025
Who Is Eligible for Chimeric Antigen Receptor T Cell Therapy? Expert Perspectives on Overcoming Referral BarriersMazyar Shadman, Sairah Ahmed, Michael T Byrne, et al.Blood|September 27, 2003
Antibody response to DBY minor histocompatibility antigen is induced after allogeneic stem cell transplantation and in healthy female donorsDavid B Miklos, Haesook T Kim, Emmanuel Zorn, et al.Journal of Neuropathology and Experimental Neurology|January 2, 2023
Multifocal demyelinating leukoencephalopathy and oligodendroglial lineage cell loss with immune effector cell-associated neurotoxicity syndrome (ICANS) following CD19 CAR T-cell therapy for mantle cell lymphomaEsther H Nie, Saman S Ahmadian, Sushma N Bharadwaj, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
A reduced-toxicity regimen is associated with durable engraftment and clinical cure of nonmalignant genetic diseases among children undergoing blood and marrow transplantation with an HLA-matched related donorKris Michael Mahadeo, Kenneth I Weinberg, Hisham Abdel-Azim, et al.Pageof 12